SUDEEPPHRM Share Price Target 2040

CAGR-based price projection for Sudeep Pharma Limited (SUDEEPPHRM) targeting 2040, derived from official NSE exchange closing prices.

Bear Case (38.7% CAGR)
Rs 116,936
2040 Target
Base Case (96.7% CAGR)
Rs 15,613,867
2040 Target
Bull Case (373.2% CAGR)
Rs 3,383,402,939,260
2040 Target

Current Market Snapshot

CMP: Rs 1,199.80
52W High: Rs 1,344.20
52W Low: Rs 609.85
1Y CAGR: 287.1%
3Y CAGR: 96.7%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,664 Rs 2,360 Rs 5,677
2028 Rs 2,308 Rs 4,644 Rs 26,862
2029 Rs 3,201 Rs 9,136 Rs 127,105
2030 Rs 4,440 Rs 17,974 Rs 601,421
2031 Rs 6,158 Rs 35,362 Rs 2,845,747
2032 Rs 8,540 Rs 69,570 Rs 13,465,231
2033 Rs 11,845 Rs 136,870 Rs 63,713,475
2034 Rs 16,428 Rs 269,275 Rs 301,473,248
2035 Rs 22,785 Rs 529,763 Rs 1,426,481,917
2036 Rs 31,602 Rs 1,042,239 Rs 6,749,688,973
2037 Rs 43,830 Rs 2,050,468 Rs 31,937,524,546
2038 Rs 60,790 Rs 4,034,027 Rs 151,118,885,355
2039 Rs 84,312 Rs 7,936,420 Rs 715,049,705,186
2040 Rs 116,936 Rs 15,613,867 Rs 3,383,402,939,260

Other SUDEEPPHRM Price Targets

2025 2026 2027 2028 2030 2035 2050

Frequently Asked Questions

What is the SUDEEPPHRM share price target for 2040?

Based on historical growth analysis, the SUDEEPPHRM share price target for 2040 ranges from Rs 116,936 (conservative) to Rs 15,613,867 (base case) to Rs 3,383,402,939,260 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of SUDEEPPHRM?

The current market price of SUDEEPPHRM (Sudeep Pharma Limited) is Rs 1,199.80. The 52-week high is Rs 1,344.20 and 52-week low is Rs 609.85.

Is SUDEEPPHRM a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for SUDEEPPHRM price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 38.7% CAGR), Base (96.7% CAGR), and Bull (optimistic at 373.2% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.